Status:
UNKNOWN
Outcome, Recuperation and Hemodynamics in Aortic Stenosis
Lead Sponsor:
Jessa Hospital
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Indication for aortic valve replacement (AVR) in aortic stenosis (AS) is currently based on the classical triad of clinical AS symptoms, estimation of AS severity, and cardiac repercussion at rest. Ho...
Eligibility Criteria
Inclusion
- Every patient above 18 years of age with an echocardiographic established moderate to severe AS
- A guideline indication for aortic valve replacement therapy
Exclusion
- Unable to perform exercise testing
- Previous aortic valve intervention
- More than moderate other valvular disease
- Patients refusing participation or unwilling to sign the informed consent
Key Trial Info
Start Date :
March 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05272020
Start Date
March 22 2021
End Date
March 31 2024
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Ziekenhuis
Hasselt, Limburg, Belgium, 3500